Sökning: "Social Pharmacy"

Visar resultat 11 - 15 av 61 avhandlingar innehållade orden Social Pharmacy.

  1. 11. Prerequisites and Responsibility for Appropriate Prescribing - the Prescribers' View

    Författare :Christina Ljungberg; Mary P. Tully; Åsa Kettis Lindblad; Petra Denig; Uppsala universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; computer-assisted drug therapy; prescription drugs; physician’s practice patterns; drug prescriptions; computerised medical records systems; continuity of patient care; hospital medication systems; drug utilisation review; responsibility; Community pharmacy services; Samhällsfarmaci; Social Pharmacy; Samhällsfarmaci;

    Sammanfattning : The overall aim of this thesis was to explore aspects of the subjective views and experiences of doctors as prescribers, focusing on responsibility for and factors of importance in achieving appropriate prescribing. To provide insights into the prescriber’s perspective the study designs were qualitative. LÄS MER

  3. 12. Multiple Medicine Use : Patients’ and general practitioners’ perceptions and patterns of use in relation to age and other patient characteristics

    Författare :Janne Moen; Lena Ring; Karolina Antonov; J. Lars G. Nilsson; Peter Noyce; Uppsala universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Age groups; Focus group interaction analysis; General practitioners; Multiple medicine use; Patient-doctor communication; Patient-related factors; Polypharmacy; Community pharmacy services; Samhällsfarmaci; Social Pharmacy; samhällsfarmaci;

    Sammanfattning : There are widespread concerns about the increasing use of multiple medicines. The aims of this thesis were to identify older patients' and general practitioners' (GPs) attitudes to and experiences of multiple medicine use, as well as to describe patterns of multiple medicine use in different age groups in association with patient-related factors. LÄS MER

  4. 13. Tinkered care: Assembling Medicine Consumption in Grey Zones

    Författare :Rui Liu; Institutionen för tjänstevetenskap; []
    Nyckelord :SAMHÄLLSVETENSKAP; SOCIAL SCIENCES; care practices; medicine consumption; tinkering; ; grey zones; health services; medical professionals; substandard and falsified medical products; Sweden;

    Sammanfattning : The aim of this dissertation is to advance knowledge about care as situated practices within and beyond medical institutional settings. It addresses the phenomenon of substandard and falsified medical products, an issue that concerns state governments globally and organisations including the World Health Organization. LÄS MER

  5. 14. eMedication – improving medication management using information technology

    Författare :Tora Hammar; Göran Petersson; Sofia Kälvemark Sporrong; Linnéuniversitetet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; NATURVETENSKAP; NATURAL SCIENCES; eMedication; eHealth; medication; ePrescribing; electronic prescribing; information technology; drug-related problems; clinical decision support system; health care; pharmacy; patient; Health Informatics; Hälsoinformatik;

    Sammanfattning : Medication is an essential part of health care and enables the prevention andtreatment of many conditions. However, medication errors and drug-relatedproblems (DRP) are frequent and cause suffering for patients and substantial costsfor society. LÄS MER

  7. 15. Use of secondary preventive drugs after stroke

    Författare :Maria Sjölander; Eva-Lotta Glader; Rune Dahlqvist; Marie Eriksson; Björn Wettermark; Umeå universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; stroke; secondary prevention; drug use; equality; medication adherence; medication beliefs; medicin; Medicine; klinisk farmakologi; Clinical Pharmacology; samhällsfarmaci; Social Pharmacy;

    Sammanfattning : Background Stroke is a serious condition that can have significant impact on an individual’s health and is a significant burden on public health and public finances. Secondary preventive drug treatment after stroke is important for decreasing the risk of recurrent strokes. LÄS MER